Dataset_ID	Sample_ID	Platform_ID	description	age	distant_rfs	er	grade	node	size	time_rfs
GSE2990	GSM65316	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65317	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65318	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65319	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65320	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65321	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65322	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65323	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65324	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65325	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65326	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65327	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65328	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65329	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65330	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65331	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65332	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65333	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65334	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65335	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65336	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65337	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65338	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65339	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65340	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65341	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65342	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65343	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65344	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65345	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65346	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65347	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65348	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65349	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65350	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65351	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65352	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65353	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65354	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65355	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65356	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65357	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65358	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65359	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65360	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65361	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65362	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65363	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65364	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65365	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65366	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65367	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65368	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65369	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65370	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65371	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65372	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65373	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65374	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65375	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65376	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65377	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65378	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	3	NA	NA	NA
GSE2990	GSM65379	GPL96	Tumor samples from Tamoxifen-only treated primary breast cancer patients	NA	NA	NA	1	NA	NA	NA
GSE2990	GSM65752	GPL96	Tumor samples from untreated primary breast cancer patients.	40	0	0	3	0	1.2	2280
GSE2990	GSM65753	GPL96	Tumor samples from untreated primary breast cancer patients.	46	0	1	1	0	1.3	2675
GSE2990	GSM65754	GPL96	Tumor samples from untreated primary breast cancer patients.	NA	1	1	1	0	6	426
GSE2990	GSM65755	GPL96	Tumor samples from untreated primary breast cancer patients.	41	1	1	3	0	3.3	182
GSE2990	GSM65756	GPL96	Tumor samples from untreated primary breast cancer patients.	38	1	1	3	0	3.2	NA
GSE2990	GSM65757	GPL96	Tumor samples from untreated primary breast cancer patients.	34	0	1	2	0	1.6	3952
GSE2990	GSM65758	GPL96	Tumor samples from untreated primary breast cancer patients.	46	1	1	2	0	2.1	1824
GSE2990	GSM65760	GPL96	Tumor samples from untreated primary breast cancer patients.	57	1	1	3	0	2.2	699
GSE2990	GSM65761	GPL96	Tumor samples from untreated primary breast cancer patients.	63	1	1	2	0	2.8	730
GSE2990	GSM65762	GPL96	Tumor samples from untreated primary breast cancer patients.	54	1	1	2	0	1.7	882
GSE2990	GSM65763	GPL96	Tumor samples from untreated primary breast cancer patients.	61	0	1	2	0	1.2	2827
GSE2990	GSM65764	GPL96	Tumor samples from untreated primary breast cancer patients.	40	0	1	2	0	2.1	2006
GSE2990	GSM65765	GPL96	Tumor samples from untreated primary breast cancer patients.	NA	0	1	2	0	1.5	2523
GSE2990	GSM65766	GPL96	Tumor samples from untreated primary breast cancer patients.	NA	0	0	1	0	1.3	3648
GSE2990	GSM65767	GPL96	Tumor samples from untreated primary breast cancer patients.	49	0	1	1	0	0.8	2250
GSE2990	GSM65768	GPL96	Tumor samples from untreated primary breast cancer patients.	62	0	0	2	0	2.3	3587
GSE2990	GSM65769	GPL96	Tumor samples from untreated primary breast cancer patients.	42	1	1	3	0	2.3	3131
GSE2990	GSM65770	GPL96	Tumor samples from untreated primary breast cancer patients.	41	1	1	1	0	1.8	2493
GSE2990	GSM65771	GPL96	Tumor samples from untreated primary breast cancer patients.	63	0	1	1	0	1	3162
GSE2990	GSM65772	GPL96	Tumor samples from untreated primary breast cancer patients.	60	0	0	2	0	1.4	3496
GSE2990	GSM65773	GPL96	Tumor samples from untreated primary breast cancer patients.	65	0	1	1	0	1.4	2158
GSE2990	GSM65774	GPL96	Tumor samples from untreated primary breast cancer patients.	44	0	1	2	0	1.6	1885
GSE2990	GSM65775	GPL96	Tumor samples from untreated primary breast cancer patients.	54	0	1	2	0	2.3	3678
GSE2990	GSM65776	GPL96	Tumor samples from untreated primary breast cancer patients.	59	1	1	1	0	2.2	1611
GSE2990	GSM65779	GPL96	Tumor samples from untreated primary breast cancer patients.	42	0	1	1	0	2	2797
GSE2990	GSM65780	GPL96	Tumor samples from untreated primary breast cancer patients.	NA	1	1	1	0	1.2	3314
GSE2990	GSM65781	GPL96	Tumor samples from untreated primary breast cancer patients.	52	0	1	1	0	1.3	3466
GSE2990	GSM65782	GPL96	Tumor samples from untreated primary breast cancer patients.	56	1	1	1	0	2.2	NA
GSE2990	GSM65783	GPL96	Tumor samples from untreated primary breast cancer patients.	49	0	1	1	0	1.1	3344
GSE2990	GSM65784	GPL96	Tumor samples from untreated primary breast cancer patients.	64	1	1	2	0	1.6	790
GSE2990	GSM65785	GPL96	Tumor samples from untreated primary breast cancer patients.	50	0	1	2	0	1.8	2189
GSE2990	GSM65786	GPL96	Tumor samples from untreated primary breast cancer patients.	56	0	1	1	0	1	1520
GSE2990	GSM65787	GPL96	Tumor samples from untreated primary breast cancer patients.	NA	0	1	2	0	2.5	1064
GSE2990	GSM65788	GPL96	Tumor samples from untreated primary breast cancer patients.	55	0	1	1	0	2.3	2189
GSE2990	GSM65789	GPL96	Tumor samples from untreated primary breast cancer patients.	65	0	1	1	0	1	2462
GSE2990	GSM65790	GPL96	Tumor samples from untreated primary breast cancer patients.	58	0	1	2	0	2.1	1642
GSE2990	GSM65791	GPL96	Tumor samples from untreated primary breast cancer patients.	58	0	1	1	0	2.2	3222
GSE2990	GSM65792	GPL96	Tumor samples from untreated primary breast cancer patients.	32	0	1	2	0	1.5	3253
GSE2990	GSM65793	GPL96	Tumor samples from untreated primary breast cancer patients.	45	0	1	2	0	1.7	1338
GSE2990	GSM65794	GPL96	Tumor samples from untreated primary breast cancer patients.	56	0	1	2	0	1.1	3162
GSE2990	GSM65795	GPL96	Tumor samples from untreated primary breast cancer patients.	50	0	1	3	0	1.9	3192
GSE2990	GSM65796	GPL96	Tumor samples from untreated primary breast cancer patients.	45	1	1	1	0	0.9	365
GSE2990	GSM65797	GPL96	Tumor samples from untreated primary breast cancer patients.	55	0	1	2	0	1.1	851
GSE2990	GSM65798	GPL96	Tumor samples from untreated primary breast cancer patients.	48	0	1	1	0	1	3435
GSE2990	GSM65799	GPL96	Tumor samples from untreated primary breast cancer patients.	62	0	1	1	0	1.8	2675
GSE2990	GSM65800	GPL96	Tumor samples from untreated primary breast cancer patients.	56	0	1	2	0	2	2280
GSE2990	GSM65801	GPL96	Tumor samples from untreated primary breast cancer patients.	51	0	1	2	0	2	3283
GSE2990	GSM65802	GPL96	Tumor samples from untreated primary breast cancer patients.	NA	0	0	3	0	2.3	2462
GSE2990	GSM65803	GPL96	Tumor samples from untreated primary breast cancer patients.	54	1	0	3	0	1.5	942
GSE2990	GSM65804	GPL96	Tumor samples from untreated primary breast cancer patients.	38	1	0	2	0	2.1	821
GSE2990	GSM65805	GPL96	Tumor samples from untreated primary breast cancer patients.	44	0	1	1	0	1.2	3070
GSE2990	GSM65806	GPL96	Tumor samples from untreated primary breast cancer patients.	38	1	0	3	0	3	61
GSE2990	GSM65807	GPL96	Tumor samples from untreated primary breast cancer patients.	51	0	1	1	0	1.3	3374
GSE2990	GSM65808	GPL96	Tumor samples from untreated primary breast cancer patients.	46	0	1	2	0	2.2	3010
GSE2990	GSM65810	GPL96	Tumor samples from untreated primary breast cancer patients.	59	0	NA	1	0	2.6	3222
GSE2990	GSM65811	GPL96	Tumor samples from untreated primary breast cancer patients.	46	0	0	2	0	1.2	213
GSE2990	GSM65812	GPL96	Tumor samples from untreated primary breast cancer patients.	NA	0	1	2	0	2.6	4347
GSE2990	GSM65813	GPL96	Tumor samples from untreated primary breast cancer patients.	NA	1	1	1	0	2.4	274
GSE2990	GSM65814	GPL96	Tumor samples from untreated primary breast cancer patients.	49	0	1	1	0	1.8	1277
GSE2990	GSM65815	GPL96	Tumor samples from untreated primary breast cancer patients.	56	1	1	1	0	2.2	2158
GSE2990	GSM65816	GPL96	Tumor samples from untreated primary breast cancer patients.	61	0	0	2	0	2.4	3648
GSE2990	GSM65817	GPL96	Tumor samples from untreated primary breast cancer patients.	36	0	1	2	0	1.2	3709
GSE2990	GSM65818	GPL96	Tumor samples from untreated primary breast cancer patients.	63	1	1	2	0	2.4	1550
GSE2990	GSM65819	GPL96	Tumor samples from untreated primary breast cancer patients.	60	0	1	3	0	2.3	4165
GSE2990	GSM65820	GPL96	Tumor samples from untreated primary breast cancer patients.	44	0	1	NA	0	0	5305
GSE2990	GSM65821	GPL96	Tumor samples from untreated primary breast cancer patients.	46	0	1	2	0	2.6	4081
GSE2990	GSM65822	GPL96	Tumor samples from untreated primary breast cancer patients.	38	1	0	2	0	1.8	3094
GSE2990	GSM65823	GPL96	Tumor samples from untreated primary breast cancer patients.	61	0	1	NA	0	0.3	5178
GSE2990	GSM65824	GPL96	Tumor samples from untreated primary breast cancer patients.	43	1	0	2	0	2	4398
GSE2990	GSM65825	GPL96	Tumor samples from untreated primary breast cancer patients.	65	0	NA	3	0	2.6	5096
GSE2990	GSM65826	GPL96	Tumor samples from untreated primary breast cancer patients.	61	1	1	NA	0	1.4	2125
GSE2990	GSM65827	GPL96	Tumor samples from untreated primary breast cancer patients.	58	0	1	NA	0	0.9	5029
GSE2990	GSM65828	GPL96	Tumor samples from untreated primary breast cancer patients.	60	1	1	NA	0	3.1	648
GSE2990	GSM65829	GPL96	Tumor samples from untreated primary breast cancer patients.	45	1	0	NA	0	1	4163
GSE2990	GSM65830	GPL96	Tumor samples from untreated primary breast cancer patients.	42	1	1	1	0	1.9	4869
GSE2990	GSM65831	GPL96	Tumor samples from untreated primary breast cancer patients.	55	0	1	3	0	3	5029
GSE2990	GSM65832	GPL96	Tumor samples from untreated primary breast cancer patients.	45	0	0	2	0	2.5	4714
GSE2990	GSM65833	GPL96	Tumor samples from untreated primary breast cancer patients.	42	1	0	3	0	2	4906
GSE2990	GSM65834	GPL96	Tumor samples from untreated primary breast cancer patients.	64	1	1	2	0	1.5	4579
GSE2990	GSM65835	GPL96	Tumor samples from untreated primary breast cancer patients.	NA	1	0	2	0	1	562
GSE2990	GSM65836	GPL96	Tumor samples from untreated primary breast cancer patients.	47	0	0	2	0	1	4605
GSE2990	GSM65837	GPL96	Tumor samples from untreated primary breast cancer patients.	64	1	1	2	0	2.1	1875
GSE2990	GSM65838	GPL96	Tumor samples from untreated primary breast cancer patients.	54	0	NA	NA	0	1	4859
GSE2990	GSM65839	GPL96	Tumor samples from untreated primary breast cancer patients.	73	1	0	3	0	4.5	252
GSE2990	GSM65840	GPL96	Tumor samples from untreated primary breast cancer patients.	48	1	1	NA	0	2	4614
GSE2990	GSM65841	GPL96	Tumor samples from untreated primary breast cancer patients.	64	1	0	2	0	1.6	3854
GSE2990	GSM65842	GPL96	Tumor samples from untreated primary breast cancer patients.	47	0	0	3	0	2.2	4683
GSE2990	GSM65843	GPL96	Tumor samples from untreated primary breast cancer patients.	39	1	0	3	0	5	2562
GSE2990	GSM65844	GPL96	Tumor samples from untreated primary breast cancer patients.	65	1	1	3	0	4.5	221
GSE2990	GSM65845	GPL96	Tumor samples from untreated primary breast cancer patients.	32	0	0	3	0	3	4598
GSE2990	GSM65846	GPL96	Tumor samples from untreated primary breast cancer patients.	NA	1	0	3	0	2.5	1038
GSE2990	GSM65847	GPL96	Tumor samples from untreated primary breast cancer patients.	64	1	1	NA	0	1.8	NA
GSE2990	GSM65848	GPL96	Tumor samples from untreated primary breast cancer patients.	60	0	1	2	0	3	4668
GSE2990	GSM65849	GPL96	Tumor samples from untreated primary breast cancer patients.	71	1	1	NA	0	2	1056
GSE2990	GSM65850	GPL96	Tumor samples from untreated primary breast cancer patients.	42	0	0	3	0	0.7	3815
GSE2990	GSM65851	GPL96	Tumor samples from untreated primary breast cancer patients.	NA	0	1	NA	0	3	4550
GSE2990	GSM65852	GPL96	Tumor samples from untreated primary breast cancer patients.	NA	1	NA	NA	0	2.5	1267
GSE2990	GSM65853	GPL96	Tumor samples from untreated primary breast cancer patients.	64	0	1	2	0	1.3	3912
GSE2990	GSM65854	GPL96	Tumor samples from untreated primary breast cancer patients.	66	0	1	NA	0	2	4477
GSE2990	GSM65855	GPL96	Tumor samples from untreated primary breast cancer patients.	47	1	0	2	0	3.8	1136
GSE2990	GSM65856	GPL96	Tumor samples from untreated primary breast cancer patients.	63	0	1	NA	0	2.4	3583
GSE2990	GSM65857	GPL96	Tumor samples from untreated primary breast cancer patients.	54	1	1	2	0	1.8	996
GSE2990	GSM65858	GPL96	Tumor samples from untreated primary breast cancer patients.	42	0	NA	1	0	1.6	4395
GSE2990	GSM65859	GPL96	Tumor samples from untreated primary breast cancer patients.	NA	0	1	2	0	2.6	4498
GSE2990	GSM65860	GPL96	Tumor samples from untreated primary breast cancer patients.	59	0	1	1	0	1.5	4473
GSE2990	GSM65861	GPL96	Tumor samples from untreated primary breast cancer patients.	71	1	0	3	0	1.9	965
GSE2990	GSM65862	GPL96	Tumor samples from untreated primary breast cancer patients.	54	0	1	1	0	1.8	4329
GSE2990	GSM65863	GPL96	Tumor samples from untreated primary breast cancer patients.	45	0	0	3	0	4	3380
GSE2990	GSM65864	GPL96	Tumor samples from untreated primary breast cancer patients.	64	1	1	NA	0	1	3666
GSE2990	GSM65865	GPL96	Tumor samples from untreated primary breast cancer patients.	43	0	0	3	0	3	4402
GSE2990	GSM65866	GPL96	Tumor samples from untreated primary breast cancer patients.	68	0	0	3	0	1.3	4078
GSE2990	GSM65867	GPL96	Tumor samples from untreated primary breast cancer patients.	63	0	1	2	0	2	4218
GSE2990	GSM65868	GPL96	Tumor samples from untreated primary breast cancer patients.	69	1	1	2	0	2	1491
GSE2990	GSM65869	GPL96	Tumor samples from untreated primary breast cancer patients.	62	1	1	3	0	3	961
GSE2990	GSM65870	GPL96	Tumor samples from untreated primary breast cancer patients.	43	1	0	3	0	2.2	2083
GSE2990	GSM65871	GPL96	Tumor samples from untreated primary breast cancer patients.	48	0	1	1	0	1	3189
GSE2990	GSM65872	GPL96	Tumor samples from untreated primary breast cancer patients.	43	1	0	3	0	2	729
GSE2990	GSM65873	GPL96	Tumor samples from untreated primary breast cancer patients.	50	0	1	1	0	0.8	1591
GSE2990	GSM65874	GPL96	Tumor samples from untreated primary breast cancer patients.	43	0	1	1	0	0.8	1920
GSE2990	GSM65875	GPL96	Tumor samples from untreated primary breast cancer patients.	70	0	1	2	0	2	3262
GSE2990	GSM65876	GPL96	Tumor samples from untreated primary breast cancer patients.	52	0	NA	1	0	2	1913
GSE2990	GSM65877	GPL96	Tumor samples from untreated primary breast cancer patients.	49	0	1	NA	0	1.3	2648
GSE2990	GSM65878	GPL96	Tumor samples from untreated primary breast cancer patients.	38	1	0	3	0	2	268
GSE2990	GSM65879	GPL96	Tumor samples from untreated primary breast cancer patients.	47	0	0	NA	0	0.9	1290
GSE2990	GSM65880	GPL96	Tumor samples from untreated primary breast cancer patients.	39	1	0	2	0	1	2297
